Umbilical cord‐derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics
Cell Proliferation · 2024-04 · 57 (4)
DOI: 10.1111/cpr.13586 ↗At a glance
Übersichtsarbeit in Cell Proliferation, published online on 2023-12-26. Written by Xixian Li and 4 co-authors. Institution: Department of Plastic Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China. Major MEDLINE topics: Rejuvenation, Mesenchymal Stem Cells. Cited 74 times so far (Crossref); 132 references. The full text is freely available (open access, CC BY 4.0). Funded by: Dalian Medical University.
Abstract (original language)
How to effectively repair cutaneous wounds and promote skin rejuvenation has always been a challenging issue for clinical medicine and medical aesthetics. Current conventional medicines exhibit several drawbacks, including limited therapeutic effects, prolonged treatment periods, and high costs. As a novel cell‐free therapy, the umbilical cord‐derived mesenchymal stem cell (UCMSC) secretome may offer a promising approach for skin regeneration and rejuvenation. The UCMSC secretome is a collection of all proteins secreted by mesenchymal stem cells, including conditioned media, exosomes, and other substances. The UCMSC secretome has numerous abilities to accelerate acute wound healing, including high fibroblast and keratinocyte proliferative activity, pro‐angiogenesis, anti‐inflammation, anti‐fibrosis, and anti‐oxidative stress. Its impact on the four stages of wound healing is manifested by inducing the haemostasis phase, inhibiting the inflammation phase, promoting the proliferation phase, and regulating the remodelling phase. Furthermore, it is highly effective in the treatment of chronic wounds, alopecia, aging, and skin homeostasis disturbance. This review focuses on the clinical therapies and application prospects of the UCMSC secretome, encompassing its source, culture, separation, identification, storage, and pretreatment. Additionally, a discussion on the dosage, administration route, efficacy, and biosafety in the clinical situation is presented. This review aims to provide scientific support for the mechanistic investigation and clinical utilisation of the UCMSC secretome in wound healing and skin rejuvenation.
Subjects
MeSH terms (MEDLINE)
Authors and institutions
- Department of Plastic Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
- CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, Liaoning, China.
- Research and Teaching Department of Comparative Medicine, Dalian Medical University, Dalian, Liaoning, China.
ORCID profiles: Xixian Li, Liang Wang
Funding
- Dalian Medical University
Cite
APA
Li, X., Zhang, D., Yu, Y., Wang, L., & Zhao, M. (2024). Umbilical cord‐derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics. Cell Proliferation, 57(4). https://doi.org/10.1111/cpr.13586
Vancouver
Li X, Zhang D, Yu Y, Wang L, Zhao M. Umbilical cord‐derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics. Cell Proliferation. 2024;57(4). doi:10.1111/cpr.13586
BibTeX
@article{Li2024,
author = {Li, Xixian and Zhang, Dan and Yu, Yang and Wang, Liang and Zhao, Muxin},
title = {Umbilical cord‐derived mesenchymal stem cell secretome promotes skin regeneration and rejuvenation: From mechanism to therapeutics},
journal = {Cell Proliferation},
year = {2024},
volume = {57},
number = {4},
doi = {10.1111/cpr.13586}
}
EUVIMED